Adagio Medical
Clinical trials sponsored by Adagio Medical, explained in plain language.
-
Freezing heart rhythms: new device aims to tame stubborn AFib
Disease control CompletedThis study tested a new freezing device (iCLAS™) to treat persistent atrial fibrillation, a type of irregular heartbeat lasting over a week. 215 adults aged 18-80 received the procedure to see if it safely restores normal rhythm. The goal was to reduce serious complications and p…
Phase: NA • Sponsor: Adagio Medical • Aim: Disease control
Last updated May 26, 2026 06:45 UTC
-
New Energy-Based heart procedures show promise for treating persistent AFib
Disease control CompletedThis study tested two new devices that use pulsed field energy to treat persistent atrial fibrillation (a type of irregular heartbeat). 89 adults who had not responded to medication received a minimally invasive heart procedure. The goal was to see if the devices are safe and can…
Phase: NA • Sponsor: Adagio Medical • Aim: Disease control
Last updated May 26, 2026 06:44 UTC
-
Freezing the heart: new hope for dangerous rhythm disorder?
Disease control CompletedThis study tested a new freezing method (cryoablation) to treat a dangerous heart rhythm called ventricular tachycardia. 64 adults who had not responded to medication took part. The goal was to see if the procedure is safe and can stop the abnormal rhythm for at least 6 months. W…
Phase: NA • Sponsor: Adagio Medical • Aim: Disease control
Last updated May 19, 2026 11:48 UTC